Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Waldstreicher

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Urology|November 20, 2003
Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasiaClaus G Roehrborn, Michael Lee, Alan Meehan, et al.
Clinical Trials (London, England)|January 11, 2014
Bumps and bridges on the road to responsible sharing of clinical trial dataJesse A Berlin, Sandra Morris, Frank Rockhold, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC)Arthur Caplan, Alison Bateman-House, Joanne Waldstreicher, et al.
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Lowering low density lipoprotein cholesterol with simvastatin, a hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, does not affect luteal function in premenopausal womenDiane Plotkin, Sam Miller, Steven Nakajima, et al.
Clinical Trials (London, England)|May 21, 2025
Concordance between clinical trial data use request proposals and corresponding publications: A cross-sectional studyEnrique Vazquez, Joseph S Ross, Cary P Gross, et al.
European Urology|July 18, 2002
Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomesClaus G Roehrborn, John D McConnell, Brian Saltzman, et al.
The Journal of Urology|February 10, 2004
Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasiaClaus G Roehrborn, Reginald Bruskewitz, J Curtis Nickel, et al.
Trials|April 10, 2026
The power, potential of real-world data in randomized controlled trials: proceedings from a multistakeholder think tankNina Nouhravesh, Jennifer G Jackman, Adrian F Hernandez, et al.
The Journal of Urology|April 17, 2002
The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trialAlvin M Matsumoto, Lisa Tenover, Michael McClung, et al.
Urology|March 18, 2003
Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasiaHunter Wessells, Johnny Roy, John Bannow, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Urology|November 20, 2003
Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasiaClaus G Roehrborn, Michael Lee, Alan Meehan, et al.
Clinical Trials (London, England)|January 11, 2014
Bumps and bridges on the road to responsible sharing of clinical trial dataJesse A Berlin, Sandra Morris, Frank Rockhold, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC)Arthur Caplan, Alison Bateman-House, Joanne Waldstreicher, et al.
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Lowering low density lipoprotein cholesterol with simvastatin, a hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, does not affect luteal function in premenopausal womenDiane Plotkin, Sam Miller, Steven Nakajima, et al.
Clinical Trials (London, England)|May 21, 2025
Concordance between clinical trial data use request proposals and corresponding publications: A cross-sectional studyEnrique Vazquez, Joseph S Ross, Cary P Gross, et al.
European Urology|July 18, 2002
Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomesClaus G Roehrborn, John D McConnell, Brian Saltzman, et al.
The Journal of Urology|February 10, 2004
Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasiaClaus G Roehrborn, Reginald Bruskewitz, J Curtis Nickel, et al.
Trials|April 10, 2026
The power, potential of real-world data in randomized controlled trials: proceedings from a multistakeholder think tankNina Nouhravesh, Jennifer G Jackman, Adrian F Hernandez, et al.
The Journal of Urology|April 17, 2002
The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trialAlvin M Matsumoto, Lisa Tenover, Michael McClung, et al.
Urology|March 18, 2003
Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasiaHunter Wessells, Johnny Roy, John Bannow, et al.
Pageof 2